Anmol Ganjoo, pharma analyst, Antique Stock Broking says one should give the company time to fix the various problems in its US business and wait before taking a view unless one sees an improvement on ground.
first published: Jul 3, 2013 02:25 pm
A collection of the most-viewed Moneycontrol videos.
Live: Can Nifty reclaim 26,000 after RS 7.5 lakh crore selloff? | IndiGo in focus | Opening Bell
Live: Sensex, Nifty fall 1% amidst broad-based selloff | Closing Bell
Live: Can Nifty reclaim record levels as investors await FOMC decision this week? | Opening Bell
Why This Tenant Says Bandra Is Better Than California | The Tenant
